Advertisement
Short communication| Volume 50, ISSUE 1, e9-e10, January 2012

Download started.

Ok

Giant cell arteritis—an incidental finding

      Abstract

      Giant cell arteritis is a systemic, inflammatory, and vascular syndrome that requires early diagnosis and immediate management because of the risk of loss of vision. Local symptoms include headache, scalp tenderness, jaw claudication, visual disturbances, and scalp necrosis. Systemic symptoms include weight loss, fever, malaise, fatigue, and polymyalgia rheumatica. We describe a case that was identified histologically as an incidental finding after excision of a basal cell carcinoma from the parietal area of the scalp. A search of PubMed and Medline using the keywords “giant cell arteritis”, and “incidental histopathological diagnosis” returned no similar previously published cases in the head and neck. We present this as an unusual and interesting case.

      Keywords

      Case report

      An 86-year-old woman presented to the department of maxillofacial surgery for wide local excision of a basal cell carcinoma from the parietal area of the scalp after referral by her general medical practitioner. Her medical history of note was previous excision of multiple cutaneous basal cell carcinomas, a lacunar infarct in 2000, and controlled hypertension. Biopsy examination confirmed diagnosis of the lesion (Fig. 1) and it was excised under local anaesthetic. Histopathological examination showed giant cell arteritis in the tissue deep to the excised tumour. The report described “striking inflammatory changes with luminal obliteration and frequent mural giant cells” (Fig. 2, Fig. 3), which is indicative of giant cell arteritis. Her C-reactive protein (CRP) was 90 mg/L (normal is up to 5), and plasma viscosity was 2.15 mPa s (normal 1.5–1.72). Although asymptomatic, she was started on a reducing course of oral prednisolone supervised by her general medical practitioner.
      Figure thumbnail gr1
      Fig. 1Completely excised basal cell carcinoma (haematoxylin and eosin, original magnification 40×).
      Figure thumbnail gr2
      Fig. 2Occluded, inflamed artery with marked transmural inflammation (haematoxylin and eosin, original magnification 100×).
      Figure thumbnail gr3
      Fig. 3High power view of artery showing prominent giant cells (haematoxylin and eosin, original magnification 200×).

      Discussion

      Giant cell arteritis occurs almost exclusively in patients over 50 years of age and varies greatly in reported incidence.
      • Bengtsson B.A.
      • Malmvall B.E.
      The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.
      • Hunder G.G.
      Epidemiology of giant-cell arteritis.
      • Sunderkötter C.
      • Sindrilaru A.
      Clinical classification of vasculitis.
      However, there is strong suggestion that the incidence is increasing even after compensation for the increasing age of the population.
      • Nordborg C.
      • Johansson H.
      • Petursdottir V.
      • Nordborg E.
      The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.
      We have described a very unusual, incidental diagnosis of giant cell arteritis in an asymptomatic patient. We know of no published reports of this in the head and neck, but similar findings have been published in gynaecological publications. Onuma et al. described an incidental finding that involved the bilateral adnexa in a 75-year-old woman.
      • Onuma K.
      • Chu C.T.
      • Dabbs D.J.
      Asymptomatic giant-cell (temporal) arteritis involving the bilateral adnexa: case report and literature review.
      Incidental findings have also been suggested on positron emission tomography computed tomography (CT) following investigation for other conditions. The abnormal finding compatible with arteritis is increased uptake of fluorodeoxyglucose in the aorta, carotid, iliac, femoral, and subclavian arteries. Two cases described were confirmed by positive biopsy findings from the temporal artery.
      • Heston T.F.
      • Szabo Z.
      Giant cell arteritis on 18F-FDG PET/CT.
      • Kathula S.K.
      • Mantil J.
      • Drehmer T.
      • Patil S.S.
      Giant cell arteritis mimicking multiple myeloma; diagnosed by PET scan.
      We diagnosed the condition pathologically and by the raised CRP. The vessel on which the diagnosis was made is most likely a parietal branch of the superficial temporal artery. CRP is a more sensitive diagnostic test for giant cell arteritis than erythrocyte sedimentation rate.
      • Hayreh S.S.
      • Podhajsky P.A.
      • Raman R.
      • Zimmerman B.
      Giant cell arteritis: validity and reliability of various diagnostic criteria.
      A diagnosis of giant cell arteritis is classed as an ophthalmological emergency as visual loss has been reported in up to 60% of patients. As biopsy examination of the temporal artery is the gold standard technique for diagnosing the condition, and because of the risk of severe complications, our patient was managed medically. Scalp necrosis is a complication,
      • Currey J.
      Scalp necrosis in giant cell arteritis and review of the literature.
      so it was interesting that the surgical site on the scalp had healed uneventfully before prednisolone had been started.

      References

        • Bengtsson B.A.
        • Malmvall B.E.
        The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.
        J Arthritis Rheum. 1981; 24: 899-904
        • Hunder G.G.
        Epidemiology of giant-cell arteritis.
        Cleve Clin J Med. 2002; 69: SII79-SII82
        • Sunderkötter C.
        • Sindrilaru A.
        Clinical classification of vasculitis.
        Eur J Dermatol. 2006; 16: 114-124
        • Nordborg C.
        • Johansson H.
        • Petursdottir V.
        • Nordborg E.
        The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.
        Rheumatology (Oxford). 2003; 42: 549-552
        • Onuma K.
        • Chu C.T.
        • Dabbs D.J.
        Asymptomatic giant-cell (temporal) arteritis involving the bilateral adnexa: case report and literature review.
        Int J Gynecol Pathol. 2007; 26: 352-355
        • Heston T.F.
        • Szabo Z.
        Giant cell arteritis on 18F-FDG PET/CT.
        Clin Physiol Funct Imaging. 2009; 29: 382-384
        • Kathula S.K.
        • Mantil J.
        • Drehmer T.
        • Patil S.S.
        Giant cell arteritis mimicking multiple myeloma; diagnosed by PET scan.
        South Med J. 2006; 99: 1280-1281
        • Hayreh S.S.
        • Podhajsky P.A.
        • Raman R.
        • Zimmerman B.
        Giant cell arteritis: validity and reliability of various diagnostic criteria.
        Am J Opthalmol. 1997; 123: 285-296
        • Currey J.
        Scalp necrosis in giant cell arteritis and review of the literature.
        Br J Rheumatol. 1997; 36: 814-816